Intellia Therapeutics
NTLA
#4677
Rank
S$2.20 B
Marketcap
$21.67
Share price
-3.24%
Change (1 day)
-33.01%
Change (1 year)

Earnings for Intellia Therapeutics (NTLA)

Earnings in 2024 (TTM): -S$0.69 Billion

According to Intellia Therapeutics's latest financial reports the company's current earnings are S$45.96 Million. In 2023 the company made an earning of -S$0.65 Billion a decrease over its 2022 earnings that were of -S$0.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intellia Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.69 Billion5.95%
2023 -S$0.65 Billion1.48%
2022 -S$0.64 Billion77.01%
2021 -S$0.37 Billion99.58%
2020 -S$0.19 Billion34.86%
2019 -S$0.14 Billion16.63%
2018 -S$0.12 Billion26.35%
2017 -S$90.87 Million113.51%
2016 -S$42.56 Million135.92%
2015 -S$18.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.17 Billion-75.41%๐Ÿ‡บ๐Ÿ‡ธ USA